Other languages Genmab A/S

Equities

GMAB

DK0010272202

Real-time Estimate Cboe Europe Other stock markets 03:35:49 2024-06-10 am EDT			5-day change	1st Jan Change
1,927 ^DKK	-0.14%		-1.71%	-10.90%

Jun. 04	Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating	MT
Jun. 03	Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study	Jun. 03
Genmab Announces Initial Data from Phase 2 Cancer Treatment Trial	Jun. 03
Genmab A/S Announces New Efficacy and Safety Data from Two Ongoing Phase 1/2 Clinical Trials Evaluating Epcoritamab, A T-Cell Engaging Bispecific Antibody Administered Subcutaneously, in Adult Patients with Certain Types of Follicular Lymphoma	Jun. 02
Genmab A/S and Biontech SE Announce Initial Data from the Phase 2 Gct1046-04 Trial (NCT05117242) Evaluating Acasunlimab	Jun. 01
Genmab A/S Reaffirms Financial Guidance for 2024	May. 21
Genmab A/S completed the acquisition of ProfoundBio, Inc.	May. 20
Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'	May. 15
Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50%	May. 15
Genmab A/S to Present New and Updated Results from Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies At the 2024 European Hematology Association Congress	May. 14
OPINIONI DEGLI ANALISTI DEL GIORNO : Italgas, Amplifon, Enel, BBVA, Aperam, Safran, Santander, Pandora, Amadeus It, Lonza, ASM International...	May. 07
AVIS D'ANALYSTES DU JOUR : Thales, Safran, Schneider, Ubisoft, Pandora, Lonza, ASM International...	May. 07
OPINIONES DE LOS ANALISTAS DEL DÍA : ACS, Vidrala, Indra Sistemas, Enagás, BBVA, Santander, Pandora, Amadeus It, Lonza, ASM International...	May. 07
OPINIONI DEGLI ANALISTI DEL GIORNO : ACS, Safran, Santander, Endesa, Amadeus It, Telefónica, Aena, Cellnex, Sixt, JCDecaux...	May. 06
AVIS D'ANALYSTES DU JOUR : Crédit Agricole, Safran, Société Générale, Vinci, Air France, Cellnex, JCDecaux...	May. 06
OPINIONES DE LOS ANALISTAS DEL DÍA : ACS, Safran, Santander, Endesa, Amadeus It, Telefónica, Aena, Cellnex, Sixt, JCDecaux...	May. 06
GENMAB : A good start to 2024; guidance unchanged	May. 03
Aggiornamento sui forti movimenti della giornata: Banks, Genmab, Daimler Truck ... risultati riassunti qui!	May. 03
Actualización de las fuertes variaciones del día: Bancos, Genmab, Daimler Truck ... ¡resultados resumidos aquí!	May. 03
Les actions en mouvement : Les banques, JCDecaux, Bonduelle ... les publications de résultats résumées ici !	May. 03
Genmab Posts Q1 Net Profit Surge; Revenue Jumps	May. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 01:08 pm EDT